Bachem Holding AG (BANB)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 82.85 |
|---|---|
| 52-week range | 48.52 – 86.00 |
| Return, 1 month / 3 months | −0.6% / +10.0% |
| Return, 1 year / 3 years | +44.8% / +29.3% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 39.4% |
| Worst drawdown (1 year) | -27.0% |
| Average daily value traded | 7.63M CHF |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bachem Holding AG is a Swiss company that makes peptides and oligonucleotides, the complex molecules used as active ingredients in modern medicines. It produces these compounds for pharmaceutical and biotechnology companies, supplying them both as research-grade materials and as ingredients for clinical and commercial drug products. The company also offers related services such as process development and manufacturing under contract. Bachem is based in Bubendorf, Switzerland, and serves customers around the world from production sites in Switzerland and elsewhere.
On this site Bachem Holding AG appears as a stock on the SIX Swiss Exchange (Switzerland), code BANB, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bachem Holding AG (BANB) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 82.85 on 23 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 58 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 44.8% and over the last three months it rose 10.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.7% | ||
| From 52-week high | -3.7% | ||
| Momentum | 80 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 10.0% | ||
| 6-month return | 23.2% | ||
| 12-month return, skipping the last month | 45.7% | ||
| Stability (higher is calmer) | 34 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.0% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 7.63M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 31 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | −0.6% |
| 3 months | +10.0% |
| 6 months | +23.2% |
| 1 year | +44.8% |
| 3 years | +29.3% |
| 5 years | −44.5% |
Signals
| 50-day / 200-day average | 79.33 / 71.60 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.55 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 May 2026 | CHF 0.4500 |
| 5 May 2025 | CHF 0.4200 |
| 26 Apr 2024 | CHF 0.4000 |
| 21 Apr 2023 | CHF 0.3700 |
| 29 Apr 2022 | CHF 1.7500 |
| 30 Apr 2021 | CHF 1.6300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.